Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)
Clinical trial NCT06504940 · RECRUITING
Trial details
- NCT number
- NCT06504940
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-28
- Primary completion
- 2027-07-08
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.